SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-236561
Filing Date
2019-09-03
Accepted
2019-09-03 16:25:32
Documents
3
Period of Report
2019-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d747520d8k.htm 8-K 26094
2 EX-10.1 d747520dex101.htm EX-10.1 98746
3 EX-99.1 d747520dex991.htm EX-99.1 13842
  Complete submission text file 0001193125-19-236561.txt   140108
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 191072364
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences